Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Johnson_&_Johnson
|
| gptkbp:acquisitionYear |
1999
|
| gptkbp:focus |
immunology
oncology gastroenterology nephrology |
| gptkbp:formerName |
gptkb:Centocor_Biotech,_Inc.
|
| gptkbp:founded |
gptkb:Centocor
|
| gptkbp:foundedYear |
1979
|
| gptkbp:founder |
gptkb:David_Holveck
gptkb:Hubert_Schoemaker gptkb:Michael_Wall |
| gptkbp:headquartersLocation |
gptkb:Horsham,_Pennsylvania,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Janssen Biotech
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:parentCompany |
gptkb:Johnson_&_Johnson
|
| gptkbp:product |
gptkb:Remicade
gptkb:Simponi gptkb:Darzalex gptkb:Procrit gptkb:Stelara |
| gptkbp:subsidiary |
gptkb:Janssen_Pharmaceuticals
|
| gptkbp:website |
https://www.janssen.com/us/biotech
|
| gptkbp:bfsParent |
gptkb:Vedanta_Biosciences
gptkb:Remicade gptkb:Simponi |
| gptkbp:bfsLayer |
5
|